Valuation: BlinkLab Limited

Market Cap 99.37M 68.91M 60.24M 55.37M 51.61M 97.88M 6.56B 665M 258M 3.23B 259M 253M 11.11B P/E 2026 *
-6.5x
P/E 2027 * -6.5x
Enterprise Value 95.37M 66.14M 57.82M 53.14M 49.53M 93.94M 6.3B 638M 248M 3.1B 248M 243M 10.67B EV / Sales 2026 *
293x
EV / Sales 2027 * 644x
Free-Float
80.71%
Yield 2026 *
-
Yield 2027 * -
1 day+0.78%
1 week+12.07%
Current month+4.84%
1 month+2.36%
3 months-18.75%
6 months-21.21%
Current year-19.75%
1 week 0.58
Extreme 0.585
0.66
1 month 0.57
Extreme 0.57
0.66
Current year 0.57
Extreme 0.57
1.07
1 year 0.4
Extreme 0.405
1.1
3 years 0.2
Extreme 0.205
1.1
5 years 0.2
Extreme 0.205
1.1
10 years 0.2
Extreme 0.205
1.1
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 2021-08-16
Chief Tech/Sci/R&D Officer - 2021-08-16
Corporate Officer/Principal - 2021-08-16
Director TitleAgeSince
Director/Board Member - 2025-12-17
Director/Board Member - 2021-08-16
Chairman - 2023-12-14
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%+12.07%+26.21% - 68.36M
+1.62%+4.70%-21.72%+15.53% 2,901B
+2.84%+14.50%-3.77%+733.12% 310B
-1.38%-7.20%+268.35%+947.04% 127B
-1.22%-1.09%+14.18%+58.51% 103B
-1.56%+8.59%+67.81%+164.89% 92.68B
-3.82%-3.78%-20.33%+0.73% 83.71B
+0.95%+13.11%-30.89%+78.91% 63.27B
+1.87%+6.90%+6.20%+72.61% 47.34B
-4.38%+16.51%-46.51%+31.62% 39.67B
Average -0.43%+8.76%+25.95%+233.66% 376.73B
Weighted average by Cap. +1.27%+10.56%-7.32%+112.43%

Financials

2026 *2027 *
Net sales 325K 225K 197K 181K 169K 320K 21.46M 2.17M 845K 10.55M 846K 828K 36.35M 145K 101K 87.91K 80.79K 75.31K 143K 9.57M 970K 377K 4.71M 377K 369K 16.22M
Net income -6.05M -4.2M -3.67M -3.37M -3.14M -5.96M -400M -40.47M -15.73M -196M -15.75M -15.41M -677M -7.4M -5.13M -4.49M -4.12M -3.84M -7.29M -489M -49.5M -19.24M -240M -19.26M -18.85M -828M
Net Debt -4M -2.77M -2.43M -2.23M -2.08M -3.94M -264M -26.76M -10.4M -130M -10.41M -10.19M -447M -6M -4.16M -3.64M -3.34M -3.12M -5.91M -396M -40.13M -15.6M -195M -15.62M -15.28M -671M
Logo BlinkLab Limited
BlinkLab Limited is an Australia-based digital healthcare company focused on Artificial intelligence (AI) powered diagnostics. The Company has fully developed a smartphone based diagnostic platform for autism, Attention-Deficit/Hyperactivity Disorder (ADHD), schizophrenia, and other neurodevelopmental conditions. Its product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as over 18 months old. Its pipeline includes BlinkLab Dx 1 and BlinkLab Dx N. Its BlinkLab Dx 1 is an autism diagnostic adjunct. Its BlinkLab Dx N is an ADHD diagnostic adjunct.
Employees
-
Date Price Change Volume
26-07-03 A$0.6500 +0.78% 103,243
26-07-02 A$0.6450 -2.27% 65,811
26-07-01 A$0.6600 +6.45% 129,135
26-06-30 A$0.6200 +2.48% 153,214
26-06-29 A$0.6050 +4.31% 174,164
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.6500AUD
Average target price
1.830AUD
Spread / Average Target
+181.54%

Annual profits - Rate of surprise